Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Miki Sugiyama"'
Autor:
Yuka Kurokawa, Yusuke Kaida, Takuma Hazama, Yosuke Nakayama, Takaomi Otome, Ryo Shibata, Sakuya Ito, Goh Kodama, Nao Nakamura, Takatoshi Kambe, Tomofumi Moriyama, Akiko Nagata, Aki Minami, Ryotaro Ando, Yoshifumi Wada, Miki Sugiyama, Michiaki Usui, Michio Chiba, Atsuo Moriyama, Atsuko Ohara, Hiroshi Miyazaki, Tatsuyuki Kakuma, Kei Fukami
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-10 (2020)
Abstract Background Etelcalcetide is the first intravenously administered calcimimetic agent used to manage secondary hyperparathyroidism (SHPT) in hemodialysis (HD) patients. We evaluated the safety and efficacy of replacing cinacalcet with etelcalc
Externí odkaz:
https://doaj.org/article/44fc4637fec249aab21820b2c2f391c2
Autor:
Aki Minami, Takuma Hazama, Tatsuyuki Kakuma, Akiko Nagata, Kei Fukami, Ryo Shibata, Miki Sugiyama, Yoshifumi Wada, Nao Nakamura, Yusuke Kaida, Ryotaro Ando, Michio Chiba, Sakuya Ito, Atsuko Ohara, Atsuo Moriyama, Michiaki Usui, Yosuke Nakayama, Tomofumi Moriyama, Goh Kodama, Takaomi Otome, Yuka Kurokawa, Hiroshi Miyazaki, Takatoshi Kambe
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-10 (2020)
Background Etelcalcetide is the first intravenously administered calcimimetic agent used to manage secondary hyperparathyroidism (SHPT) in hemodialysis (HD) patients. We evaluated the safety and efficacy of replacing cinacalcet with etelcalcetide in
Autor:
Masumi Kimoto, Kensei Taguchi, Sakuya Ito, Kei Fukami, Daisuke Saigusa, Miki Sugiyama, Sho-ichi Yamagishi, Yosuke Nakayama, Ryotaro Ando, Takaaki Abe, Junko Yano, Yusuke Kaida, Miyuki Yokoro, Seiji Ueda
Publikováno v:
Journal of the American Society of Nephrology. 28:2670-2680
Erythropoietin-resistant anemia is associated with adverse cardiovascular events in patients with ESRD, but the underlying mechanism remains unclear. Here, we evaluated the role of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarg
Autor:
Kaoru Ueda, Kensei Taguchi, Goh Kodama, Miki Sugiyama, Tomohisa Minezaki, Junko Yano, Yusuke Kaida, Chika Yoshida, Nao Nakamura, Akiko Nagata, Yuka Kurokawa, Sho-ichi Yamagishi, Yosuke Nakayama, Tomofumi Moriyama, Kazutaka Shibatomi, Kei Fukami, Sakuya Ito
Publikováno v:
Clinical and Experimental Nephrology. 22:35-44
Hyperkalemia is prevalent in end-stage renal disease patients, being involved in life-threatening arrhythmias. Although polystyrene sulfonate (PS) is commonly used for the treatment of hyperkalemia, direct comparison of effects between calcium and so
Publikováno v:
Open Journal of Radiology. :130-142
Background: Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA; gadoxetic acid disodium, Primovist, Bayer Healthcare, Berlin, Germany) is a gadolinium based contrast agent with hepatocyte specific properties. In patients scanned
Autor:
Makoto Nasu, Yoshifumi Wada, Ryo Shibata, Yuka Kurokawa, Yusuke Kaida, Tomofumi Moriyama, Takuma Hazama, Kyoko Tashiro, Yukie Kinoshita, Yoshihiko Otsubo, Junko Yano, Kei Fukami, Goh Kodama, Kaoru Nakano, Takuya Ariyoshi, Ryuji Iwatani, Kengo Urae, Miki Sugiyama
Publikováno v:
Nutrients
Volume 13
Issue 6
Nutrients, Vol 13, Iss 1900, p 1900 (2021)
Volume 13
Issue 6
Nutrients, Vol 13, Iss 1900, p 1900 (2021)
L-carnitine (LC) supplementation improves cardiac function in hemodialysis (HD) patients. However, whether reducing LC supplementation affects carnitine kinetics and cardiac function in HD patients treated with LC remains unclear. Fifty-nine HD patie
Autor:
Hiroyuki Kobayashi, Miki Sugiyama, Hiroko Nonomura, Saki Shimato, Takuji Mizuki, Ryusei Nishiyama, Daisuke Kishigai, Masae Okuyama, Akiko Pawlak, Hiroyasu Murasawa, Yasushi Hirasawa, Kazutaka Katayama, Takahito Imaizumi, Nozomu Shimato
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. 94:2-P1
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. 92:2
Publikováno v:
Virus Genes. 41:389-395
Complete nucleotide sequences were determined for subtype B avian metapneumovirus (aMPV), the attenuated vaccine strain VCO3/50 and its parental pathogenic strain VCO3/60616. The genomes of both strains comprised 13,508 nucleotides (nt), with a 42-nt
Autor:
Aki Minami, Sakuya Ito, Nao Nakamura, Aki Kojima, Yosuke Nakayama, Takaomi Otome, Junko Yano, Tomofumi Moriyama, Miki Sugiyama, Goh Kodama, Yoshimi Takamiya, Yuri Kumabe, Kei Fukami, Yuka Kurokawa, Ryo Shibata, Yusuke Kaida, Takuma Hazama, Akiko Nagata
Publikováno v:
Nephrology Dialysis Transplantation. 33:i243-i243